DOI : 10.1055/s-00000054

Pharmacopsychiatry

Issue 02 · Volume 53 · March 2020 DOI: 10.1055/s-010-45977


Abstracts of the 2nd Symposium of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) and Deutsche Gesellschaft für Biologische Psychiatrie (DGBP)
Seminaris Campus Hotel Berlin, 04.–06.03.2020

Due to safety considerations in connection with the spread of SARS-CoV-2, this meeting was cancelled. Should it be held at a later date, we will inform you here.

Editors: Jürgen Deckert, WürzburgManfred Gerlach, WürzburgJohannes Thome, Rostock
Abstracts (HTML) Abstracts (PDF) List of Authors
P2.1
Cho, AB; Otte, K; Baskow, I; Ehlen, F; Maslahati, T; Mansow-Model, S; Schmitz-Hübsch, T; Behnia, B; Roepke, S: Detecting motor function abnormalities in individuals with Autism Spectrum Disorder without intellectual impairment via visual-perceptive computing
P2.2
Gründahl, M; Retzlaff, L; Andreatta, M; Hein, G: The effect of social influence on relief-learning
P2.3
Meixensberger, S; Tebartz van Elst, L; Runge, K; Endres, D: Cerebrospinal fluid findings in patients with severe mental disorders
P2.4
Radtke, F; Holweck, J; Geissler, J; Strork, T; Drepper, C; Fouskova, Z; Gerlach, M; Fischer, M; Romanos, M: Olfactory function, transcranial sonography and fear generalization in patients with 22q11.2 deletion syndrome along the lifespan
P2.5
Runge, K; Tebartz van Elst, L; Kuzior, H; Fiebich, BL; Endres, D: Elevated interleukin-8 levels in the cerebrospinal fluid of patients with Schizophrenia Spectrum Disorders
P2.6
Schmidt, FM; Wozniak, D; Pelz, JO; Scheller, E; Boettcher, E; Schreiber, L: Investigation of cross-section area of the vagus nerve, heart rate variability and inflammatory markers in major depression
P2.7
Lüno, M; Meyer-Lotz, G; Metzger, C; Gescher, D; Hoeschen, C; Gbauoui, L; Frodl, T: Breathomics for depressive disorders
P2.8
Engelmann, J; Dreimüller, N; Lieb, K; Tadic, A; Wollschläger, D; Wagner, S: The development of body mass index (BMI) in depressed patients during an antidepressant treatment and its effects on depressive symptomatology
P2.9
Meiberth, D; Hu, X; Schild, AK; Spottke, A; Brosseron, F; Buerger, K; Fliessbach, K; Heneka, MT; Kilimann, I; Laske, C; Peters, O; Priller, J; Schneider, A; Teipel, S; Wiltfang, J; Wagner, M; Duezel, E; Jessen, F; Study group DELCODE: Alzheimerʼs Disease biomarkers and cortical thickness in persons reporting subjective cognitive decline and healthy controls: Data derived from the DZNE DELCDODE-Study
P2.10
Klinger-König, J; Frenzel, S; Wittfeld, K; Van der Auwera, S; Homuth, G; Hannemann, A; Bülow, R; Völzke, H; Grabe, HJ: Cortisol, aging and the influence on brain age
P2.11
Kaczmarczyk, M; Spitzer, C; Wingenfeld, K; Wiedemann, K; Kühl, L; Schultebraucks, K; Otte, C: No association between major depression with and without childhood adversity and the stress hormone copeptin
P2.12
Hacke, M; Signoret-Genest, J; Tovote, P; Romanos, M: Definition, detection and differentiation of acute emotional states using heart rate recording
P2.13
Seidenbecher, S: Structural brain characteristics associated with appetitive aggression in martial artists